Reaction
Complement Factor Increased reporting signals
As of the last recalculation, Complement Factor Increased appears in 82 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is ECULIZUMAB (PRR 198.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Eculizumab | 28 | 198.1 | 198.2 |
| Belimumab | 14 | 135.2 | 135.2 |
| Ravulizumab | 4 | 78.9 | 79.0 |